Liposomal Bupivacaine for Pain Control After Rotator Cuff Repair
Primary Purpose
Rotator Cuff Tear, Postoperative Pain
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Liposomal bupivacaine (LB)
Sponsored by
About this trial
This is an interventional supportive care trial for Rotator Cuff Tear
Eligibility Criteria
Inclusion Criteria:
- at least 18 years of age
- undergoing an arthroscopic rotator cuff repair surgery of a full thickness tear
- willing to fill out the "Pain Journal"; able to understand the informed consent process
- willing to document informed consent prior to completion of any study-related procedure
- able to read, comprehend, and complete subject-reported outcome measures in English
Exclusion Criteria:
- pregnant
- documented history of drug or alcohol abuse
- use of narcotic painkillers greater than 3 months prior to surgery
- neurologic deficit or disability involving the surgical extremity
- known allergy or intolerance to hydrocodone or oxycodone
- known allergy to amide anesthetics
- currently enrolled or planning to enroll in another clinical trial during this study that would affect the outcome of this study
- history of cognitive or mental health status that interferes with study participation
Sites / Locations
- Orthopaedic & Neurosurgery Specialists
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Liposomal Bupivacaine (LB)
Interscalene Block Alone (ISB)
Arm Description
Administration of 20 ml of LB diluted with an additional 40 ml of saline was injected into a triangular soft tissue surgical field block, along with standard bupivacaine interscalene block
Administration of 20mL of 0.5% standard bupivacaine interscalene block with no additional soft tissue surgical field block
Outcomes
Primary Outcome Measures
Daily Opioid Consumption in Oral Morphine Equivalent
Total amount of narcotics consumed over the study period following surgery
Secondary Outcome Measures
Visual Analog Scale Pain Scores
A standardized measure of subjective pain on a scale of 0 to 10, from zero pain to excruciating pain, respectively
Full Information
NCT ID
NCT03692546
First Posted
September 26, 2018
Last Updated
September 30, 2018
Sponsor
Orthopaedic & Neurosurgery Specialists
1. Study Identification
Unique Protocol Identification Number
NCT03692546
Brief Title
Liposomal Bupivacaine for Pain Control After Rotator Cuff Repair
Official Title
Liposomal Bupivacaine Reduces Opiate Consumption After Rotator Cuff Repair in a Randomized Control Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
February 1, 2017 (Actual)
Primary Completion Date
March 1, 2018 (Actual)
Study Completion Date
September 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Orthopaedic & Neurosurgery Specialists
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
The use of an interscalene block (ISB) is often associated with rebound pain that could be avoided through adjunctive therapy with longer duration. Administration of a liposomal bupivacaine (LB) field block in addition to ISB would overcome this rebound pain to provide greater pain relief and reduce opiate consumption when compared to ISB alone. 50 patients were recruited and randomized into groups that either received or did not receive an intraoperative LB field block in addition to standard ISB administration. Visual Analog Scale (VAS) pain scores and narcotic consumption were recorded over the five-day postoperative period to determine the effectiveness of LB pain relief.
Detailed Description
Arthroscopic rotator cuff repair (ARCR) provides excellent clinical outcomes but is often associated with significant postoperative pain. As rotator cuff repair procedures become increasingly more common, these procedures and the narcotic prescriptions which accompany them may contribute to the rising opioid epidemic. The use of intraoperative local and regional anesthesia or field blocks, in conjunction with multimodal pharmacological strategies, is a widely accepted approach for managing surgical pain and reducing opiate use. The purpose of this study was to determine whether using a field block of liposomal bupivacaine (LB) in addition to an interscalene block (ISB) would provide greater pain relief and reduction in opiate consumption when compared to ISB alone.
The study enrolled 50 patients undergoing primary ARCR surgery. Patients were randomized to receiving intraoperative liposomal bupivacaine or not and provided with postoperative "Pain Journals" to document their daily pain on a visual analog scale (VAS) and to track their daily opioid consumption during the first five post-operative days.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rotator Cuff Tear, Postoperative Pain
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Liposomal Bupivacaine (LB)
Arm Type
Experimental
Arm Description
Administration of 20 ml of LB diluted with an additional 40 ml of saline was injected into a triangular soft tissue surgical field block, along with standard bupivacaine interscalene block
Arm Title
Interscalene Block Alone (ISB)
Arm Type
No Intervention
Arm Description
Administration of 20mL of 0.5% standard bupivacaine interscalene block with no additional soft tissue surgical field block
Intervention Type
Drug
Intervention Name(s)
Liposomal bupivacaine (LB)
Other Intervention Name(s)
EXPAREL
Intervention Description
Addition of LB solution to soft tissue surgical field block to a standard interscalene block procedure
Primary Outcome Measure Information:
Title
Daily Opioid Consumption in Oral Morphine Equivalent
Description
Total amount of narcotics consumed over the study period following surgery
Time Frame
Post-operative day one to five
Secondary Outcome Measure Information:
Title
Visual Analog Scale Pain Scores
Description
A standardized measure of subjective pain on a scale of 0 to 10, from zero pain to excruciating pain, respectively
Time Frame
Post-operative day one to five
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
at least 18 years of age
undergoing an arthroscopic rotator cuff repair surgery of a full thickness tear
willing to fill out the "Pain Journal"; able to understand the informed consent process
willing to document informed consent prior to completion of any study-related procedure
able to read, comprehend, and complete subject-reported outcome measures in English
Exclusion Criteria:
pregnant
documented history of drug or alcohol abuse
use of narcotic painkillers greater than 3 months prior to surgery
neurologic deficit or disability involving the surgical extremity
known allergy or intolerance to hydrocodone or oxycodone
known allergy to amide anesthetics
currently enrolled or planning to enroll in another clinical trial during this study that would affect the outcome of this study
history of cognitive or mental health status that interferes with study participation
Facility Information:
Facility Name
Orthopaedic & Neurosurgery Specialists
City
Greenwich
State/Province
Connecticut
ZIP/Postal Code
06831
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
16086570
Citation
Barber FA. Suprascapular nerve block for shoulder arthroscopy. Arthroscopy. 2005 Aug;21(8):1015. doi: 10.1016/j.arthro.2005.05.033.
Results Reference
background
PubMed Identifier
29426743
Citation
Boddu C, Genza A, McCann PD. Bridging multimodal pain management provides 48-hour pain control in patients undergoing total shoulder replacement. J Shoulder Elbow Surg. 2018 Jun;27(6S):S65-S69. doi: 10.1016/j.jse.2017.12.026. Epub 2018 Feb 13.
Results Reference
background
PubMed Identifier
15570231
Citation
Boss AP, Maurer T, Seiler S, Aeschbach A, Hintermann B, Strebel S. Continuous subacromial bupivacaine infusion for postoperative analgesia after open acromioplasty and rotator cuff repair: preliminary results. J Shoulder Elbow Surg. 2004 Nov-Dec;13(6):630-4. doi: 10.1016/j.jse.2004.04.005.
Results Reference
background
PubMed Identifier
22285545
Citation
Bramlett K, Onel E, Viscusi ER, Jones K. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee. 2012 Oct;19(5):530-6. doi: 10.1016/j.knee.2011.12.004. Epub 2012 Jan 28.
Results Reference
background
PubMed Identifier
21654552
Citation
Chan CW, Peng PW. Suprascapular nerve block: a narrative review. Reg Anesth Pain Med. 2011 Jul-Aug;36(4):358-73. doi: 10.1097/AAP.0b013e3182204ec0.
Results Reference
background
PubMed Identifier
27676661
Citation
Chang KV, Wu WT, Hung CY, Han DS, Yang RS, Chang CH, Lin CP. Comparative Effectiveness of Suprascapular Nerve Block in the Relief of Acute Post-Operative Shoulder Pain: A Systematic Review and Meta-analysis. Pain Physician. 2016 Sep-Oct;19(7):445-56.
Results Reference
background
PubMed Identifier
23466172
Citation
Ensor KL, Kwon YW, Dibeneditto MR, Zuckerman JD, Rokito AS. The rising incidence of rotator cuff repairs. J Shoulder Elbow Surg. 2013 Dec;22(12):1628-32. doi: 10.1016/j.jse.2013.01.006. Epub 2013 Mar 1.
Results Reference
background
PubMed Identifier
28804154
Citation
Jacob BC, Peasah SK, Shogbon AO, Perlow ER. Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital. Hosp Pharm. 2017 May;52(5):367-373. doi: 10.1177/0018578717715382. Epub 2017 May 1.
Results Reference
background
PubMed Identifier
28226333
Citation
Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, Calixto F, Bolden JL, Urman RD, Manchikanti L. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Pain Physician. 2017 Feb;20(2S):S93-S109.
Results Reference
background
PubMed Identifier
28182507
Citation
Kumar K, Gulotta LV, Dines JS, Allen AA, Cheng J, Fields KG, YaDeau JT, Wu CL. Unused Opioid Pills After Outpatient Shoulder Surgeries Given Current Perioperative Prescribing Habits. Am J Sports Med. 2017 Mar;45(3):636-641. doi: 10.1177/0363546517693665. Epub 2017 Feb 9.
Results Reference
background
PubMed Identifier
29305103
Citation
McLaughlin DC, Cheah JW, Aleshi P, Zhang AL, Ma CB, Feeley BT. Multimodal analgesia decreases opioid consumption after shoulder arthroplasty: a prospective cohort study. J Shoulder Elbow Surg. 2018 Apr;27(4):686-691. doi: 10.1016/j.jse.2017.11.015. Epub 2018 Jan 3.
Results Reference
background
PubMed Identifier
25911660
Citation
Morris BJ, Mir HR. The opioid epidemic: impact on orthopaedic surgery. J Am Acad Orthop Surg. 2015 May;23(5):267-71. doi: 10.5435/JAAOS-D-14-00163.
Results Reference
background
PubMed Identifier
27856266
Citation
Routman HD, Israel LR, Moor MA, Boltuch AD. Local injection of liposomal bupivacaine combined with intravenous dexamethasone reduces postoperative pain and hospital stay after shoulder arthroplasty. J Shoulder Elbow Surg. 2017 Apr;26(4):641-647. doi: 10.1016/j.jse.2016.09.033. Epub 2016 Nov 15.
Results Reference
background
PubMed Identifier
28844420
Citation
Sabesan VJ, Shahriar R, Petersen-Fitts GR, Whaley JD, Bou-Akl T, Sweet M, Milia M. A prospective randomized controlled trial to identify the optimal postoperative pain management in shoulder arthroplasty: liposomal bupivacaine versus continuous interscalene catheter. J Shoulder Elbow Surg. 2017 Oct;26(10):1810-1817. doi: 10.1016/j.jse.2017.06.044. Epub 2017 Aug 24.
Results Reference
background
PubMed Identifier
28301454
Citation
Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):265-269. doi: 10.15585/mmwr.mm6610a1.
Results Reference
background
PubMed Identifier
28326395
Citation
Snyder MA, Scheuerman CM, Gregg JL, Ruhnke CJ, Eten K. Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension. Arthroplast Today. 2016 Jan 11;2(1):37-42. doi: 10.1016/j.artd.2015.05.005. eCollection 2016 Mar.
Results Reference
background
PubMed Identifier
29599038
Citation
Syed UAM, Aleem AW, Wowkanech C, Weekes D, Freedman M, Tjoumakaris F, Abboud JA, Austin LS. Neer Award 2018: the effect of preoperative education on opioid consumption in patients undergoing arthroscopic rotator cuff repair: a prospective, randomized clinical trial. J Shoulder Elbow Surg. 2018 Jun;27(6):962-967. doi: 10.1016/j.jse.2018.02.039. Epub 2018 Mar 26.
Results Reference
background
PubMed Identifier
19535272
Citation
Tashjian RZ, Deloach J, Porucznik CA, Powell AP. Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. J Shoulder Elbow Surg. 2009 Nov-Dec;18(6):927-32. doi: 10.1016/j.jse.2009.03.021. Epub 2009 Jun 16.
Results Reference
background
PubMed Identifier
27545048
Citation
Tashjian RZ, Hung M, Keener JD, Bowen RC, McAllister J, Chen W, Ebersole G, Granger EK, Chamberlain AM. Determining the minimal clinically important difference for the American Shoulder and Elbow Surgeons score, Simple Shoulder Test, and visual analog scale (VAS) measuring pain after shoulder arthroplasty. J Shoulder Elbow Surg. 2017 Jan;26(1):144-148. doi: 10.1016/j.jse.2016.06.007. Epub 2016 Aug 18.
Results Reference
background
PubMed Identifier
24815964
Citation
Tong YC, Kaye AD, Urman RD. Liposomal bupivacaine and clinical outcomes. Best Pract Res Clin Anaesthesiol. 2014 Mar;28(1):15-27. doi: 10.1016/j.bpa.2014.02.001. Epub 2014 Mar 15.
Results Reference
background
PubMed Identifier
27079219
Citation
Uquillas CA, Capogna BM, Rossy WH, Mahure SA, Rokito AS. Postoperative pain control after arthroscopic rotator cuff repair. J Shoulder Elbow Surg. 2016 Jul;25(7):1204-13. doi: 10.1016/j.jse.2016.01.026. Epub 2016 Apr 11.
Results Reference
background
PubMed Identifier
28326386
Citation
Webb BT, Spears JR, Smith LS, Malkani AL. Periarticular injection of liposomal bupivacaine in total knee arthroplasty. Arthroplast Today. 2015 Oct 12;1(4):117-120. doi: 10.1016/j.artd.2015.09.001. eCollection 2015 Dec.
Results Reference
background
PubMed Identifier
29249547
Citation
Welton KL, Kraeutler MJ, McCarty EC, Vidal AF, Bravman JT. Current pain prescribing habits for common shoulder operations: a survey of the American Shoulder and Elbow Surgeons membership. J Shoulder Elbow Surg. 2018 Jun;27(6S):S76-S81. doi: 10.1016/j.jse.2017.10.005. Epub 2017 Dec 14.
Results Reference
background
Citation
Wertheim H, Rovenstine E. Suprascapular nerve block. Anesthesiology: The Journal of the American Society of Anesthesiologists. 1941;2(5):541-545.
Results Reference
background
PubMed Identifier
28571723
Citation
Westermann RW, Anthony CA, Bedard N, Glass N, Bollier M, Hettrich CM, Wolf BR. Opioid Consumption After Rotator Cuff Repair. Arthroscopy. 2017 Aug;33(8):1467-1472. doi: 10.1016/j.arthro.2017.03.016. Epub 2017 May 29.
Results Reference
background
PubMed Identifier
28682872
Citation
Yan Z, Chen Z, Ma C. Liposomal bupivacaine versus interscalene nerve block for pain control after shoulder arthroplasty: A meta-analysis. Medicine (Baltimore). 2017 Jul;96(27):e7226. doi: 10.1097/MD.0000000000007226.
Results Reference
background
Learn more about this trial
Liposomal Bupivacaine for Pain Control After Rotator Cuff Repair
We'll reach out to this number within 24 hrs